Parental concern towards the use of inhaled therapy in children with chronic asthma

P W Chan1, J A DeBruyne

  • 1Department of Paediatrics, University Malaya Medical Center, Kuala, Lumpar, Malaysia. patrick@medicine.med.um.edu.my

Insights

Parental concerns about inhaled asthma therapy, particularly side effects and dependency, are common and linked to poor treatment adherence in children. Addressing these concerns through education is crucial for improving asthma management.

Area of Science:

  • Pediatric Pulmonology
  • Asthma Management
  • Pharmacotherapy Adherence

Background:

  • Parental attitudes significantly impact adherence to inhaled therapy for pediatric asthma.
  • Understanding parental perceptions is key to improving treatment outcomes.

Purpose of the Study:

  • To evaluate parental perceptions and concerns regarding inhaled therapy for children with chronic asthma.

Main Methods:

  • A self-administered questionnaire was used to survey parents of children requiring inhaled steroids.
  • Data was collected from parents attending a Paediatric Asthma Clinic.

Main Results:

  • 66% of parents expressed concerns about inhaled therapy, primarily citing side effects (91%) and inhaler dependency (86%).
  • Concerns were associated with beliefs favoring oral therapy and higher steroid doses.
  • Children of concerned parents were more likely to miss inhaled steroid doses (46% vs. 22%) and require more nebulization treatments.

Conclusions:

  • A significant portion of parents have concerns about inhaled asthma therapy, negatively affecting treatment adherence.
  • Targeted parental education is essential to enhance asthma management and improve adherence to inhaled treatments.
Abstract

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: